Bionevix Ltd develops endothelial‑targeted, non‑cytotoxic antibody‑drug conjugates that deliver prec Sign up to read more
No filings found for this company.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| BENJAMIN EMMANUEL SCHREIBER | ORDINARY | 950,000 | 95.0% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
1 more shareholder on file , sign up free to see.
Companies with the most similar business descriptions.
Accounts not filed